Insiders · Profile

Warmuth Markus

President & CEO at Monte Rosa Therapeutics. Filing since 5 Jan 2026. CIK 0001855643

Company

Date

Role

Action

Shares

Amount

Of holding

GLUE Monte Rosa Therapeutics, Inc.

16 Jul 2026

President & CEO

Sold at will

9,500

$220.22K

1.6%

GLUE Monte Rosa Therapeutics, Inc.

1 Jun 2026

President & CEO

Sold on a plan

5,466

$106.25K

0.9%

GLUE Monte Rosa Therapeutics, Inc.

1 May 2026

President & CEO

Sold on a plan

5,467

$103.45K

0.9%

GLUE Monte Rosa Therapeutics, Inc.

14 Apr 2026

President & CEO

Sold at will

8,000

$141.12K

1.3%

GLUE Monte Rosa Therapeutics, Inc.

2 Mar 2026

President & CEO

Sold on a plan

5,466

$97.97K

0.9%

GLUE Monte Rosa Therapeutics, Inc.

7 Jan 2026

President & CEO

Sold on a plan

5,466

$128.37K

0.9%

GLUE Monte Rosa Therapeutics, Inc.

5 Jan 2026

President & CEO

Sold at will

10,135

$153.75K

1.6%

7 decisions on file.